Abstract
Microsponges are polymeric delivery systems consisting of porous microspheres having a size range in between 5 to 300 μm depending upon the degree of smoothness or after feel required for the end formulations. Microsponge Delivery System MDS is a unique technology for controlled delivery of drug. The present review introduces Microsponge technology along with its synthesis, characterization, programmable parameters and release mechanism of MDS. Wide ranges of applications are also suggested to develop drug or cosmetic products with enhanced safety and efficacy. MDS can provide increased efficacy for topically active agents with enhanced safety, extended product stability and improved aesthetic properties in an efficient and novel manner.
Keywords: Microsponge, quasi emulsion diffusion solvent method, free radical suspension polymerization, porous microsphere, release mechanism
Current Drug Delivery
Title: Microsponge Delivery System
Volume: 4 Issue: 2
Author(s): Vikrant Chadawar and Jessy Shaji
Affiliation:
Keywords: Microsponge, quasi emulsion diffusion solvent method, free radical suspension polymerization, porous microsphere, release mechanism
Abstract: Microsponges are polymeric delivery systems consisting of porous microspheres having a size range in between 5 to 300 μm depending upon the degree of smoothness or after feel required for the end formulations. Microsponge Delivery System MDS is a unique technology for controlled delivery of drug. The present review introduces Microsponge technology along with its synthesis, characterization, programmable parameters and release mechanism of MDS. Wide ranges of applications are also suggested to develop drug or cosmetic products with enhanced safety and efficacy. MDS can provide increased efficacy for topically active agents with enhanced safety, extended product stability and improved aesthetic properties in an efficient and novel manner.
Export Options
About this article
Cite this article as:
Chadawar Vikrant and Shaji Jessy, Microsponge Delivery System, Current Drug Delivery 2007; 4 (2) . https://dx.doi.org/10.2174/156720107780362320
DOI https://dx.doi.org/10.2174/156720107780362320 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of C-Reactive Protein in Atherosclerotic Cardiovascular Disease: An Overview
Current Vascular Pharmacology Serum Selenium Levels in Patients with Remission and Relapse of Graves Disease
Medicinal Chemistry Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines
CNS & Neurological Disorders - Drug Targets Long-Term Treatment With Raltegravir is Associated with Lower Triglycerides and Platelets Count in the Older HIV+ Population: Results from the Ral-Age Study
Current HIV Research Technological Options for the Production of Health-Promoting Proteins and Peptides Derived from Milk and Colostrum
Current Pharmaceutical Design The Potentials of Selected Therapeutic Targets for Inflammation: A Snapshot
Recent Patents on Inflammation & Allergy Drug Discovery Micro-RNA in Disease and Gene Therapy
Current Drug Discovery Technologies Identification and Detection of Transmissible Spongiform Encephalopathies
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents COVID-19 Invades Several Important Organs other than the Lungs: Organs Crosstalk
Coronaviruses Recently Patented Viral Nucleotide Sequences and Generation of Virus-Derived Vaccines
Recent Patents on Anti-Infective Drug Discovery Mechanisms And Prevention Of TAVI-Related Cerebrovascular Events
Current Pharmaceutical Design Editorial [Hot Topic: ADAMs: Targets for Drug Discovery (Executive Editor: Marcia L. Moss)]
Current Pharmaceutical Design Role of LXR and ABCA1 in the Pathogenesis of Alzheimers Disease -Implications for a New Therapeutic Approach
Current Alzheimer Research The Use of Citrullinated Peptides for the Diagnosis and Prognosis of Rheumatoid Arthritis
Current Topics in Medicinal Chemistry Inhibitory Effects of Some Bryophytes on Glutathione-S -Transferase
Current Enzyme Inhibition Inflammatory Aspects of Depression
Inflammation & Allergy - Drug Targets (Discontinued) Dental Caries and Vaccination Strategy against the Major Cariogenic Pathogen, Streptococcus mutans
Current Pharmaceutical Biotechnology Low Osteopontin N-Terminal Fragment and Carotid Plaque Stability Associated with Statin or Antiplatelet Therapy
Current Vascular Pharmacology Tailored Multi-Target Agents. Applications and Design Considerations
Current Pharmaceutical Design Trends in the Analysis of Biopharmaceuticals by HPLC
Current Analytical Chemistry